254 related articles for article (PubMed ID: 17998146)
1. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Malago M; Steveling K; Reis H; Cicinnati VR; Schmid KW; Baba HA
J Hepatol; 2008 Jan; 48(1):83-90. PubMed ID: 17998146
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of p70S6 kinase predicts overall survival in patients with clear margin-resected hepatocellular carcinoma.
Baba HA; Wohlschlaeger J; Cicinnati VR; Hilgard P; Lang H; Sotiropoulos GC; Takeda A; Beckebaum S; Schmitz KJ
Liver Int; 2009 Mar; 29(3):399-405. PubMed ID: 18492014
[TBL] [Abstract][Full Text] [Related]
3. Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis.
Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Kaiser GM; Schmid KW; Baba HA
J Clin Pathol; 2009 Aug; 62(8):690-3. PubMed ID: 19638539
[TBL] [Abstract][Full Text] [Related]
4. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
Huo TI; Huang YH; Hsia CY; Su CW; Lin HC; Hsu CY; Lee PC; Lui WY; Loong CC; Chiang JH; Chiou YY; Lee SD
Liver Int; 2009 May; 29(5):767-73. PubMed ID: 19018974
[TBL] [Abstract][Full Text] [Related]
6. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
[TBL] [Abstract][Full Text] [Related]
7. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
[TBL] [Abstract][Full Text] [Related]
8. Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations.
Schmitz KJ; Wohlschlaeger J; Alakus H; Bohr J; Stauder MA; Worm K; Winde G; Schmid KW; Baba HA
Virchows Arch; 2007 Feb; 450(2):151-9. PubMed ID: 17149612
[TBL] [Abstract][Full Text] [Related]
9. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.
Okano J; Nagahara T; Matsumoto K; Murawaki Y
Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):543-51. PubMed ID: 18346049
[TBL] [Abstract][Full Text] [Related]
10. COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
Foster J; Black J; LeVea C; Khoury T; Kuvshinoff B; Javle M; Gibbs JF
Ann Surg Oncol; 2007 Feb; 14(2):752-8. PubMed ID: 17146741
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma.
Morinaga S; Tarao K; Yamamoto Y; Nakamura Y; Rino Y; Miyakawa K; Ohkawa S; Akaike M; Sugimasa Y; Takemiya S
J Gastroenterol Hepatol; 2007 Aug; 22(8):1249-55. PubMed ID: 17688665
[TBL] [Abstract][Full Text] [Related]
12. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
13. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
Yoshida T; Hisamoto T; Akiba J; Koga H; Nakamura K; Tokunaga Y; Hanada S; Kumemura H; Maeyama M; Harada M; Ogata H; Yano H; Kojiro M; Ueno T; Yoshimura A; Sata M
Oncogene; 2006 Oct; 25(45):6056-66. PubMed ID: 16652141
[TBL] [Abstract][Full Text] [Related]
14. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
15. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival.
Zhang XF; Meng B; Qi X; Yu L; Liu C; Liu XM; Wang B; Pan CE; Lv Y
Eur J Surg Oncol; 2009 Jun; 35(6):622-8. PubMed ID: 18835514
[TBL] [Abstract][Full Text] [Related]
17. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
19. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of survival and risk of hepatocellular carcinoma in patients with cirrhosis of mixed (viral, alcoholic) etiology].
Lopatkina TN; Tanashchuk EL; Siutkin VE; Popova IV
Ter Arkh; 2002; 74(2):44-6. PubMed ID: 11899824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
